Synaffix adds Boehringer and Mitsubishi Tanabe as ADC licensing partners

Anna Brown

News Reporter

Lonza’s Synaffix has secured two separate licensing deals with Boehringer Ingelheim and Japanese drugmaker Mitsubishi Tanabe Pharma for its antibody-drug conjugate tech.

The two long …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Synaffix adds Boehringer and Mitsubishi Tanabe as ADC licensing partners

Anna Brown

News Reporter

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Versant unveils Light Horse with $62M and a partnership with Novartis

After lackluster 2024, biopharma industry prays stalled M&A will finally move into gear

IGM Biosciences’ autoimmune pivot lasts three months after interim data disappoint

Exclusive: First-of-its-kind infant DNA edit leads to apparent cure in disease that set back field 25 years ago

Aiolos team reunites with $411M for new biotech with obesity drugs from China

Shoreline cuts staff as its partnership with Gilead's Kite is now in flux

Synaf­fix adds Boehringer and Mit­subishi Tan­abe as ADC li­cens­ing part­ners

News Reporter

Sign up to read this article for free.

more like this

Bachem

Bubendorf, BL, Switzerland

Synaffix adds Boehringer and Mitsubishi Tanabe as ADC licensing partners